The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of prognostic genomic biomarkers in metastatic clear cell renal cell carcinoma (mccRCC): An analysis of the large retrospective real world clinico-genomic data from Flatiron Health (FH)-Foundation Medicine, Inc. (FMI) clinico-genomic database (CGDB).
 
Mimma Rizzo
Honoraria - Janssen Oncology; MSD
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Gilead Sciences; Janssen Oncology; Merck Serono; MSD Oncology
Speakers' Bureau - MSD Oncology
Research Funding - AstraZeneca (Inst); MSD (Inst); Roche (Inst)
Expert Testimony - MSD Oncology
 
Gaetano Pezzicoli
Honoraria - Merck Serono
Research Funding - Merck Serono
 
Camilla Porta
Consulting or Advisory Role - Janssen (Inst); Novartis (Inst); Roche Italy (Inst); Sanofi (Inst)
Research Funding - Janssen (Inst); Novartis (Inst); Roche Italy (Inst); Sanofi (Inst)
 
Massimiliano Povero
Consulting or Advisory Role - Janssen (Inst); Novartis (Inst); Roche Italy (Inst); Sanofi (Inst)
Research Funding - Janssen (Inst); Novartis (Inst); Roche Italy (Inst); Sanofi (Inst)
 
Lorenzo Pradelli
Honoraria - Fresenius Kabi
Research Funding - Leading a consultancy mainly financed by research grants
 
Emilia Sicari
Employment - Roche Italy
Stock and Other Ownership Interests - Roche
 
Valentina Sara Barbiero
Employment - Roche Italy
Stock and Other Ownership Interests - Roche
 
Camillo Porta
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Genenta Science; Ipsen; Merck Serono; MSD
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Lilly; MSD; MSD
Travel, Accommodations, Expenses - Ipsen; MSD